Drug Profile
PTX 2416
Alternative Names: SYN 2416Latest Information Update: 08 Feb 2007
Price :
$50
*
At a glance
- Originator NAEJA Pharmaceutical
- Class Antibacterials; Monobactams
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 16 Oct 2001 Preclinical development for Bacterial infections in Canada (unspecified route)